Cytosorbents (CTSO) Net Shares Issued and Repurchased (2017 - 2026)

Cytosorbents (CTSO) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $797847.0 the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 1602.04% year-over-year to $797847.0; the trailing twelve-month figure through Mar 2026 stood at $797847.0 (up 1602.04% YoY), and the FY2025 full-year result was $1.8 million, down 55.29% from the prior year.
• Net Shares Issued and Repurchased retreated to $797847.0 in Q1 2026 per CTSO's latest filing, from $1.8 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $4.1 million in Q4 2022 and bottomed at $40000.0 in Q2 2024.
• Historically, Net Shares Issued and Repurchased has averaged $1.5 million across 5 years, with a median of $951486.0 in 2022.
• The sharpest annual moves came in 2025 and 2026: Net Shares Issued and Repurchased plunged 88.78% in 2025, then soared 1602.04% in 2026.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.1 million in 2022, then tumbled by 36.33% to $2.6 million in 2023, then jumped by 53.08% to $4.0 million in 2024, then tumbled by 55.29% to $1.8 million in 2025, then sank by 55.19% to $797847.0 in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $797847.0, $1.8 million, and $46876.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.